WT1 and leukemia: These four major WT1 isoforms are overexpressed in solid tumors and leukemias, having varying oncogenic functions that promote cellular proliferation [26], survival [26,28–30], angiogenesis [31], cell migration and invasion [32], anti-apoptotic actions [33], and contribute to epithelial to mesenchymal transition [34].